Lupus and Allied Diseases Association Donates $150,000 to Advance Lupus Research
Our deepest thanks go to the Lupus and Allied Diseases Association, Inc. (LADA) for their extremely generous donation of $150,000 to...
Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis
Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis
The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced a partnership with the biopharmaceutical company Nkarta, Inc. in developing the engineered natural killer (NK) cell therapy NKX019 as a potential treatment for people with refractory lupus nephritis who have not responded to standard treatment.
The full press release is available on the Lupus Therapeutics website.
